Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Canadian (TSX) Pharma Industry Analysis

UpdatedAug 06, 2026
DataAggregated Company Financials
Companies51
  • 7D-0.7%
  • 3M-15.0%
  • 1Y11.9%
  • YTD-10.2%

The Pharma industry is up 3.3% in the last week, with Apotex Health up 3.6%. Meanwhile, Cronos Group actually underperformed within the industry, shrinking 5.9% in the last week. This takes the industry's 12 month performance to a gain of 13%. Looking forward, earnings are forecast to grow by 13% annually.

Industry Valuation and Performance

Has the Canadian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 06 Aug 2026CA$13.3bCA$10.6b-CA$1,700,145,211.779.9x-7.8x1.3x
Sat, 04 Jul 2026CA$14.4bCA$10.7b-CA$1,738,526,373.729.9x-8.3x1.3x
Mon, 01 Jun 2026CA$16.9bCA$12.1b-CA$1,891,923,461.118.2x-8.9x1.4x
Wed, 29 Apr 2026CA$17.3bCA$11.2b-CA$1,666,869,246.5215.3x-10.4x1.5x
Fri, 27 Mar 2026CA$13.7bCA$11.4b-CA$1,715,612,273.2811.8x-8x1.2x
Sun, 22 Feb 2026CA$14.2bCA$11.2b-CA$1,902,820,914.1914.6x-7.5x1.3x
Tue, 20 Jan 2026CA$16.5bCA$11.3b-CA$1,956,205,258.7316.1x-8.5x1.5x
Thu, 18 Dec 2025CA$20.6bCA$11.3b-CA$1,946,220,786.9415.6x-10.6x1.8x
Sat, 15 Nov 2025CA$14.6bCA$11.4b-CA$1,945,599,646.9414.9x-7.5x1.3x
Mon, 13 Oct 2025CA$17.2bCA$11.3b-CA$2,040,987,138.2035.1x-8.4x1.5x
Wed, 10 Sep 2025CA$17.0bCA$11.2b-CA$2,035,900,083.7238.1x-8.4x1.5x
Fri, 08 Aug 2025CA$12.5bCA$11.8b-CA$2,564,822,923.4718.2x-4.9x1.1x
Sun, 06 Jul 2025CA$10.1bCA$11.7b-CA$2,527,776,876.4717.2x-4x0.9x
Tue, 03 Jun 2025CA$9.8bCA$11.7b-CA$2,517,617,470.0519.4x-3.9x0.8x
Thu, 01 May 2025CA$10.5bCA$11.9b-CA$2,501,480,895.9320.9x-4.2x0.9x
Sat, 29 Mar 2025CA$10.5bCA$12.3b-CA$2,594,338,733.3519.5x-4x0.9x
Mon, 24 Feb 2025CA$12.0bCA$12.1b-CA$2,216,892,701.0621.8x-5.4x1x
Wed, 22 Jan 2025CA$12.6bCA$12.1b-CA$2,409,230,307.5728.9x-5.2x1x
Fri, 20 Dec 2024CA$12.6bCA$12.1b-CA$2,600,855,126.3719.4x-4.8x1x
Sun, 17 Nov 2024CA$14.9bCA$12.0b-CA$2,653,132,502.2016.2x-5.6x1.2x
Tue, 15 Oct 2024CA$18.4bCA$11.8b-CA$2,699,739,851.4518.1x-6.8x1.6x
Thu, 12 Sep 2024CA$18.0bCA$11.6b-CA$2,700,699,947.5520.5x-6.7x1.6x
Sat, 10 Aug 2024CA$19.3bCA$11.7b-CA$2,648,771,519.6723.6x-7.3x1.6x
Mon, 08 Jul 2024CA$19.0bCA$11.7b-CA$3,191,241,919.1818.5x-6x1.6x
Wed, 05 Jun 2024CA$20.9bCA$11.7b-CA$2,744,782,781.5213x-7.6x1.8x
Fri, 03 May 2024CA$25.2bCA$11.8b-CA$3,422,844,135.8311.7x-7.4x2.1x
Sun, 31 Mar 2024CA$25.0bCA$11.9b-CA$3,482,675,772.549.3x-7.2x2.1x
Tue, 27 Feb 2024CA$22.5bCA$12.0b-CA$4,647,759,588.679.5x-4.8x1.9x
Thu, 25 Jan 2024CA$21.0bCA$12.4b-CA$6,769,620,806.009.6x-3.1x1.7x
Sat, 23 Dec 2023CA$17.0bCA$12.2b-CA$6,715,146,418.008.6x-2.5x1.4x
Mon, 20 Nov 2023CA$18.0bCA$12.5b-CA$6,837,871,349.007.1x-2.6x1.4x
Wed, 18 Oct 2023CA$18.7bCA$12.4b-CA$7,330,037,148.0013.3x-2.5x1.5x
Fri, 15 Sep 2023CA$21.7bCA$12.9b-CA$7,891,240,783.0015.1x-2.7x1.7x
Sun, 13 Aug 2023CA$14.2bCA$13.1b-CA$8,044,261,319.0011.9x-1.8x1.1x
Price to Earnings Ratio

-1.8x


Total Market Cap: CA$14.2bTotal Earnings: -CA$8,044,261,319.00Total Revenue: CA$13.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Canadian Pharma Industry Price to Earnings3Y Average -5.9x202420252026
Current Industry PE
  • Investors are pessimistic on the Canadian Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 1.4x is higher than the industry's current PS ratio of 1.2x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 6.8% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Trends

Which industries have driven the changes within the Canadian Healthcare industry?

CA Market2.02%
Healthcare-1.12%
Pharma-0.73%
Pharma-0.73%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
APTX Apotex HealthCA$37.503.6%
+CA$301.6m		n/aPE22.9x
VREO Vireo GrowthCA$13.905.3%
+CA$34.5m		-42.1%PS1.4x
CRDL Cardiol TherapeuticsCA$1.9016.6%
+CA$31.1m		28.4%PB9x
HITI High TideCA$3.1810.6%
+CA$26.8m		5.1%PS0.4x
WEED Canopy GrowthCA$1.304.8%
+CA$25.3m		-9.7%PS1.9x

Latest News

VRNO
CA$7.35
Verano Holdings
7D
-0.9%
1Y
27.8%
ACB
CA$4.06
Aurora Cannabis
7D
6.3%
1Y
-30.1%
GRIN
CA$0.59
Grown Rogue International
7D
9.3%
1Y
9.3%
GTII
CA$9.31
Green Thumb Industries
7D
-4.0%
1Y
-1.8%
HITI
CA$3.18
High Tide
7D
10.6%
1Y
5.1%
VREO
CA$13.90
Vireo Growth
7D
5.3%
1Y
-42.1%
CPH
CA$16.92
Cipher Pharmaceuticals
7D
3.4%
1Y
31.7%
GUD
CA$9.26
Knight Therapeutics
7D
-6.2%
1Y
47.2%
XLY
CA$2.62
Auxly Cannabis Group
7D
-3.0%
1Y
24.8%
HLS
CA$4.12
HLS Therapeutics
7D
-3.1%
1Y
-17.8%
WEED
CA$1.30
Canopy Growth
7D
4.8%
1Y
-9.7%
CURA
CA$11.71
Curaleaf Holdings
7D
-0.4%
1Y
69.0%
Narrative Update • Jul 23

CURA: International Supply Deals And Spain Approval Will Support Future Upside Potential

Analysts have raised their CA$ price target on Curaleaf Holdings by CA$1, citing updated assumptions for fair value, revenue growth, profit margins and future P/E multiples that, in their view, better reflect the company’s outlook. What’s in the News for Curaleaf Holdings Curaleaf International Limited entered a long term international supply agreement with Cannara Biotech Inc.
NVRS
CA$0.94
Noveris Health Sciences
7D
-15.3%
1Y
276.0%
APTX
CA$37.50
Apotex Health
7D
3.6%
1Y
n/a
CRON
CA$3.80
Cronos Group
7D
-5.9%
1Y
31.9%
CRDL
CA$1.90
Cardiol Therapeutics
7D
16.6%
1Y
28.4%
Analysis Article • Jun 04

Is Cardiol Therapeutics (TSE:CRDL) In A Good Position To Invest In Growth?

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...